$PBM

$3.40 +$0.39 (12.96%) Close

$PBM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 2.3M shares outstanding

Who owns PBM?

By type of holder

Institutions 16.1% Everyone else 83.9%

No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".

Concentration Top 10 holders own 158.7%

Psyence Labs Ltd. 115.3% · KAOS Capital Ltd. 13.7%

Institutional ownership

16.1%

+9.5 pts vs last qtr

Institutional holders

+7 vs last qtr

Net shares bought

+217.3K

by institutions in Q2 2026

New / sold out

7 / 0

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

AdvisorShares Investments LLC NEW +122.2K
Morgan Stanley NEW +37.8K

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Psyence Biomedical Ltd in the last 12 months.

Is your stake being diluted?

There are not yet two fiscal years of reported share counts for Psyence Biomedical Ltd.

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years41% Under 1 year59%

Quarterly turnover

71.8%

of institutional shares changed hands

Top 10 managers, median time held

0 quarters

Super Investors

Investment managers reporting PBM on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
PA Parallel Advisors, LLC	151.3K	6.60%	Unchanged	2025	0.0%
Shares held by quarter Peak holding275.0K (Q2'25) Change over 8 quarters+151.3K Share of the company6.600% Parallel Advisors, LLC's full portfolio →
AI AdvisorShares Investments LLC	122.2K	5.33%	NEW	Q2 '26	0.1%
Shares held by quarter Peak holding122.2K (Q2'26) Change over 8 quarters+122.2K Share of the company5.330% AdvisorShares Investments LLC's full portfolio →

Parallel Advisors, LLC

151.3K

% of company

6.60%

Change vs last qtr

Unchanged

Held since

2025

AdvisorShares Investments LLC

122.2K

% of company

5.33%

Change vs last qtr

NEW

Held since

Q2 '26

7 more super investors behind a free account

See every manager holding Psyence Biomedical Ltd, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting PBM on Form N-PORT; together they hold 5.3% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
AP AdvisorShares Psychedelics ETF AdvisorShares Trust	$374K	122.2K	5.33%	0.84%	June 30, 2026

AdvisorShares Psychedelics ETF

AdvisorShares Trust

Position value

$374K

% of company

5.33%

% of the fund

0.84%

As of

June 30, 2026

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
PL Psyence Labs Ltd. 5%+ holder 13D · 49.8%	2.6M	115.28%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company115.280% Disclosed stake13D · 49.8% View the 13D/G filing →
KC KAOS Capital Ltd. 5%+ holder 13D · 4.9%	313.9K	13.69%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company13.690% Disclosed stake13D · 4.9% View the 13D/G filing →

Psyence Labs Ltd.

5%+ holder13D · 49.8%

2.6M

% of company

115.28%

Change vs last qtr

—

Held since

—

KAOS Capital Ltd.

5%+ holder13D · 4.9%

313.9K

% of company

13.69%

Change vs last qtr

—

Held since

—

1 more holders behind a free account

See every insider and 5%+ holder of Psyence Biomedical Ltd.

Comments